Lianyungang, China

Ding Yu

This inventor holds 2 USPTO granted patents and 7 published patent applications. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ding Yu. Retrieved from https://idiyas.com/inventor/ding-yu-mrzk5kpp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ding Yu

Introduction

Ding Yu is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hemophagocytic syndrome. His work exemplifies the intersection of innovation and medical science.

Latest Patents

Ding Yu holds a patent for the "Use of pyrrolopyrimidine compound for treating hemophagocytic syndrome." This invention relates to the use of a pyrrolopyrimidine compound, specifically a compound of formula (I), its stereoisomers, or pharmaceutically acceptable salts, in the treatment of this serious medical condition. His patent highlights the potential of this compound in developing effective therapies.

Career Highlights

Throughout his career, Ding Yu has worked with prominent pharmaceutical companies, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Lianyungang Runzhong Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Ding Yu has collaborated with several professionals in his field, including Hongming Liang and Xiquan Zhang. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Ding Yu's contributions to the pharmaceutical industry, particularly through his patent for treating hemophagocytic syndrome, demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…